Skip to main content
. Author manuscript; available in PMC: 2008 Dec 1.
Published in final edited form as: Arch Neurol. 2008 Apr 14;65(6):716–723. doi: 10.1001/archneur.2008.65.6.nct70003

Table 1.

Characteristics of study participants according to quintiles of baseline serum urate (n=804).

Quintile of baseline serum urate
1 2 3 4 5 All
Serum urate (mg/dL) <4.3 4.3–<5.1 5.1–<5.8 5.8–<6.7 >=6.7
N. of patients 177 157 147 169 154 804
Female % 74.6 44.6 25.2 15.4 14.3 35.7
Age (median) 57 60 59 61 60 59
BMI 25.0 26.2 27.8 28.7 29.9 27.5
Current smokers % 6.2 5.1 14.3 5.3 5.2 7.1
Gout % 0 0.6 0.7 1.2 5.2 1.5
Hypertension (% use of antihypertensive drugs) 19.8 26.8 36.1 37.3 57.1 35.0
Thiazides % 5.7 6.4 10.2 14.2 16.2 10.4
NSAIDs use % 27.7 29.3 29.9 20.7 30.5 27.5
Endpoint: Yes % 67.8 61.8 64.0 59.2 53.3 61.3
UPDRS rate of change during follow-up (mean) 16.9 17.0 14.8 14.1 14.3 14.9
% change in striatal β-CIT uptake (mean) − 10 −9 −10 −8 −4 −8